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1. Introduction
  The continuous use of antibiotics in clinical practice 
has been the direct cause of the development of 
multiple antibiotic resistances among bacteria causing 
human infection[1]. To combat such bacterial resistance 
to antibiotic, scientists discovered natural sources 
like medicinal plants of non-antibiotic drugs having 
antibacterial potentiality[2-4]. Beside the medicinal plants, 
the antibacterial activity of honey against many different 
life threatening bacteria has been reported[5-8]. Wilkinson 
[9] determined the activity of 13 different honey samples, 
including three commercial antibacterial honeys, against 
Escherichia coli (E. coli) and Pseudomonas aeruginosa 
(P. aeruginosa). It has been reported that honey showed 
both bacteriostatic and bactericidal effect against gram 
positive as well as gram-negative bacteria, and also 
exhibited anti-fungal activity[10,11]. Chauhan et al[12] 
reported that the minimum inhibitory concentration (MIC) 
and minimum bactericidal concentration (MBC) of honey 
ranged 0.625-5.000 mg/mL for the clinical isolates of E. 
coli, P. aeruginosa and Salmonella enterica serovar Typhi 
(S. enterica serovar Typhi). Another study revealed honey 
MIC 11% for Pseudomonas isolates[13]. Moreover, honey 
represents the oldest traditional medicines in the treatment 
of respiratory ailment, gastrointestinal infection and various 
other diseases. It is being used effectively as a dressing for 
wounds (including surgical wounds), burns, and skin ulcers 
to reduce pain and odour quickly. Molan[14] documented an 
array of supportive evidences ranging from case reports to 
randomized controlled trials mentioning the value of honey 
in wound care, particularly its antibacterial activity. Honey 
has been reported to maintain moist wound environment 
that promotes healing, and its high viscosity helps to 
provide a protective barrier to prevent infection; in addition, 
the mild acidity and low-level hydrogen peroxide release 
help in tissue repairing and contribute to the antibacterial 
activity[15]. However, from our part of the country no report 
has been documented based upon the scientific study on 
antibacterial activity of honey. Herein, we report the in vitro 
antibacterial activity of honey produced by honeybees (Apis 
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indica) (A. indica) against clinical isolates of E. coli, P. 
aeruginosa and S. enterica serovar Typhi. 
2. Materials and method
2.1. Bacterial strains and media
  A total of 18 bacterial isolates that included E. coli (n=5), 
P. aeruginosa (n=5) and S. enterica serovar Typhi (n=8), 
obtained respectively from urinary tract infection cases 
by urine cultures, human skin lesion by pus cultures and 
suspected enteric fever patients by blood cultures, at the 
Calcutta School of Tropical Medicine, Kolkata, India were 
assessed. The E. coli ATCC 25922 strain was used as the 
control. Urine, pus and blood samples from suspected 
patients were cultured using McConkey agar, blood agar and 
brain heart infusion broth, respectively, for the recovery of 
E. coli, P. aeruginosa and S. enterica serovar Typhi. 
2.2. Processing of honey for antibacterial activity
  Honey sample, harvested from A. indica hive during spring 
2007, from a village of district Purulia, West Bengal (India) 
in sterile screwed cups was used in the study. The honey 
sample was filtered through a sterile cheese cloth to remove 
debris, autoclaved at 121 曟 for 15 min, streaked on blood 
agar and nutrient agar plates in duplicate, and incubated for 
24 h at 35 曟 to check microbial purity. The pH of the honey 
was checked and stored at 4 曟 until used. 
2.3. Antibacterial activity
  Antimicrobial activity of honey for the bacterial isolates 
has been determined by agar dilution method[16]. Molten 
nutrient agar (Hi-Media, Mumbai, India) was distributed 
(20 mL each) in 12 sterile culture tubes and autoclaved at 
121 曟 for 15 min. The tubes containing media were held in 
water bath (55 曟) to add honey at different concentrations 
(50, 100, 150, 200, 250, 300, 350, 400, 500, 600, 700 and 800 毺L), 
which were equivalent to honey concentrations 0.25%, 
0.50%, 0.75%, 1.00%, 1.25%, 1.50%, 1.75%, 2.00%, 2.50%, 
3.00%, 3.50% and 4.00% (v/v), respectively. The media 
from the tubes were plated to obtain 12 culture plates each 
containing different concentrations of honey as mentioned 
above. The plates thus prepared were divided into 18 equal 
sectors for spot inoculation of the test microorganisms. After 
inoculation, with 104 CFU/spot, the plates were incubated 
for 24 h at 35 曟. The nutrient agar plate without honey was 
similarly inoculated to control the appropriate growth of the 
organisms. Results were noted in terms of bacterial growth 
on the agar plates.
2.4. Interpretation of results
  The partial inhibitory concentration (PIC) was reported as 
the lowest concentration of honey that retarded growth as 
compared to the control plate, and the minimum inhibitory 
concentration (MIC) was reported as the lowest concentration 
of honey required for inhibiting the visible growth of the 
isolates. The minimum bactericidal concentration (MBC) was 
determined by further sub culturing the last plate, which 
showed visible growth, and all the plates in which there was 
no growth on agar medium. The MBC was thus the lowest 
concentration of honey required to produce sterile culture.
2.5. In vitro killing activity
  Killing activity of honey against three bacterial strains:  S. 
enterica serovar Typhi D1/01, E. coli EC4 and P. aeruginosa 
PS1 (randomly selected) were determined by using the initial 
inoculum of 5伊105 CFU/mL (5.698 log10 CFU/mL) of nutrient 
broth followed by incubation for 24 h at 35 曟. Honey 
concentrations used for the study ranged from 0.50% (v/v) to 
5.00% (v/v). Bactericidal activity was defined as a ≥3 log10 
decrease in the inoculum after 24 h of incubation[17]. 
3. Results 
  The PICs, MICs and MBCs of honey (pH 3.5) for the isolates 
of S. enterica serovar Typhi (n=8), E. coli (n=5) and P. 
aeruginosa (n=5) are represented in Figure 1. The PIC 
values for the isolates ranged variously: 0.50%-1.25% (v/v) 
for S. enterica serovar Typhi, 0.75%-1.50% (v/v) for E. coli 
and 1.00%-1.25% (v/v) for P. aeruginosa. The P. aeruginosa 
isolates showed top MIC value of honey (3.50%, v/v), while 
the MICs of honey ranged between 3.00% and 3.50% (v/v) for 
E. coli isolates, and from 1.75% to 3.00% (v/v) for S. enterica 
serovar Typhi isolates. The P. aeruginosa and E. coli isolates 
had high MBC value of 4.00% (v/v); the S. enterica serovar 
Typhi showed MBCs in between 3.00% and 3.50% (v/v).
  The effect of different concentration of honey, ranging 
from 0.50% to 4.00% (v/v), on the growth of S. enterica 
serovar Typhi, P. aeruginosa and E. coli is represented in 
Figure 2. The bacterial strains grew well in presence of 0.50% (v/
v). The honey started to show growth inhibitory effect at 
concentration 1.00% (v/v) for S. enterica serovar Typhi and 
E. coli, and 1.50% (v/v) for P. aeruginosa. Bactericidal 
activity of honey was achieved at concentration 3.00% (v/
v) for S. enterica serovar Typhi and E. coli, and at 3.50% 
(v/v) for P. aeruginosa. Growth of S. enterica serovar 
Typhi, E. coli and P. aeruginosa was completely inhibited 
beyond concentrations 3.00%, 3.50% and 4.00% (v/v) honey, 
respectively.
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Figure 1. PIC, MIC and MBC of honey for S. enterica serovar Typhi 
(S. typhi), E. coli and P. aeruginosa isolates.
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Figure 2. Effect of different concentration of honey on the growth of 
S. enterica serovar Typhi (S. typhi), E. coli and P. aeruginosa isolates.
4. Discussion
  It has been reported that the honey produced by honeybees 
(A. mellifera) inhibited most of the test organisms at 
concentrations 2.5%-7.5% (v/v)[18], while this value was 
1.75%-3.50% in the present communication. Chauhan et al[12] 
reported that the most susceptible bacteria, in a study with 
honey, included Salmonella typhi, E. coli and P. aeruginosa having 
MICs and MBCs of honey in the range of 0.625-5 .000 mg/mL, and 
ZDI for the isolates ranged 6.94-37.94 mm, respectively. Mulu 
et al[18] reported that the tualang honey had more PIC (a 
lower concentration that retarded growth) than the manuka 
honey. When tested against S. enterica serovar Typhi and 
P. aeruginosa, tualang honey and manuka honey had equal 
MICs (15% and 17.5%, respectively), while the values were 
17.5%-22.5% for E. coli[5]; in the same study, the MBCs 
were recorded as 17.5%-20%, 22.5%-25% and 17.5%-25%, 
respectively, for S. enterica serovar Typhi and P. aeruginosa 
and E. coli, while the ZDIs for the bacterial isolates were 24 
mm for tualang honey and 26 mm for manuka honey. Asadi-
Pooya et al[19] documented that the growth of mycobacteria 
was inhibited at honey concentrations of 10% and 20% but 
not at 5%, 2.5% or 1% concentration. Agbagwa and Frank-
Peterside[20] reported ZDI in between 3 mm and 17 mm for 
four different pathogenic bacterial genera due to honey 
action from different parts of Nigera. The honey sample, 
in the present study, exhibited PIC (bacteriostatic) at 
concentrations 0.50%-1.25%, and bactericidal activities 
for all the test microorganisms at concentrations 3.00%-
4.00% (v/v), based on the agar dilution techniques. When 
in vitro time-kill study was considered, the honey showed 
bactericidal activity at 3.00% (v/v) for S. enterica serovar 
Typhi and E. coli, and at 3.50% (v/v) for P. aeruginosa. The 
≥ 3 log10 decrease in CFU/mL (3.264 log10, 3.378 log10, and 
3.508 log10 CFU/mL decrease, respectively, for S. enterica 
serovar Typhi, E. coli, and  P. aeruginosa), compared to the 
initial inocula of 5.698 log10 CFU/mL, after 24 h incubation 
supported the phenomena. 
  The current study showed that honey has less antimicrobial 
activity against P. aeruginosa as compared with the other 
test microorganisms, S. enterica serovar Typhi and E. coli. 
The high PICs (1.00%-1.25%) and MIC (3.50%) of honey for 
all the isolates of P. aeruginosa supported this view too. 
The wide range of MICs of different honeys against the 
same class of microorganisms has been reported illustrating 
differences in antibacterial potency of different honeys[15]. 
The average MIC and MBC of honey for test bacterial 
isolates were recorded as 6.2% and 8% (v/v), respectively[21]. 
Among different honeys tested, the Khadikraft honey was 
found best with 11% MIC; the other types of honeys had 
MIC of 20% against P. aeruginosa[22]. The antimicrobial 
effect of honey samples against S. aureus and S. epidermidis 
was found different that in turn indicated difference in the 
sensitivity of these bacteria to the antimicrobial activity 
of honey[23]. Thus, the above fact underlines the value of 
using a standardized medical grade honey that demonstrates 
consistent antibacterial activity against a broad range of 
microorganisms. 
  The honey produced by honeybees (A. mellifera) showed 
both bacteriostatic and bactericidal activity when tested in 
vitro, as has been reported by Mulu et al[18]. Honey, at 60% 
concentration, was found bacteriocidal for P. aeruginosa and 
bacteriostatic for S. aureus and Klebsiella sp[24]. The findings 
of the present study are in resonance with the above. The 
variation in the antimicrobial potency of honey has been 
reported too. The concentration of honey for full prevention 
of growth of E. coli, as has been reported by Mulu et al[18] 
was 6.5%, and for P. aeruginosa the value was 7.5%. Basson 
et al[10] demonstrated that the honey concentration needed 
for complete growth inhibition of S. anginosus and S. oralis 
were 17% and 12.5%, respectively. Growth retardation and 
complete inhibition have been observed at concentrations 
2.5% and 6% (v/v), respectively, as has been reported by 
Mulu et al[21]. French et al[25] reported that the growth of 
Staphylococcus isolates was inhibited by manuka and 
pasture honeys at concentrations 2.7-5% (v/v), whereas the 
simulated honey inhibited the test isolates at concentrations 
27.5-31.7% (v/v), showing 5.5-11.7 times greater antibacterial 
activity of natural honeys; such activity was due to the 
osmotic effect of the sugar content of honey. In the current 
study, the values were recorded as 3.00%-3.50% for E. 
coli isolates, and 3.50% for P. aeruginosa isolates. The S. 
enterica serovar Typhi isolates in our study showed lower 
PICs (0.50%-1.25%) and MICs (1.75%-3.00%) of honey.
  The variation in the antimicrobial potential of honey used 
in the present study as compared to the others might be 
due to differences in growth rate of pathogens, inoculum 
size and the test method it self, as well as source of the 
microorganisms. Tan et al[5] stated that honey is produced 
from many sources, and its antimicrobial activity varies 
greatly with origin and processing. Also, it might be the 
fact that the type of honey produced by honeybees is 
dependent on the natural vegetative flowers blooming in 
different seasons and in different places, and thus the 
flowers from which bees gathered nectar to produce the 
honey may contribute to the difference in the antimicrobial 
activities of honey[18]. Several earlier authors reported 
that the antimicrobial activities have been attributed to its 
high acidic nature (pH being 3.2-4.5), high osmotic effect, 
hydrogen peroxide concentration and its phytochemical 
nature; beside this, it has been reported that methylglyoxal, 
which is present in high concentration in manuka honey, 
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is directly responsible for its characteristic antibacterial 
property[26-28]. In the present study, we used autoclaved 
honey that showed excellent antibacterial activity in vitro, 
which suggests that the antibacterial activity of honey 
is not dependent alone on its phytochemical nature, i.e. 
tetracycline derivatives, ascorbic acid, peroxidase or 
amylases, streptomycin, sulfonamides, which are reported 
as heat labile. We checked the pH of the honey as 3.5. The 
honey when added to the media lowers the pH of the media 
up to 6 to 6.5, which might inhibit the bacterial growth with 
other factors, in the media. 
  In conclusion, the honey showed excellent antibacterial 
activity against E. coli, P. aeruginosa and S. enterica serovar 
Typhi, related respectively to the urinary tract infection, 
skin lesion and enteric fever among human patients, and 
thus the honey may be considered against such common 
infection. The antimicrobial properties as a topical agent 
has been described and documented both in in vitro 
and in vivo studies and evidence supports its usefulness 
in wound healing[29]. However, further studies include 
pharmacological standardization and clinical evaluation 
on the effect of honey in order to consider it (honey) as a 
preventive and curative measure to the infection caused by 
the test bacterial strains.
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